Arrowhead Pharmaceuticals (ARWR) Q2 2026 Earnings

7MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-1.26
-0.77
-0.27
0.22

Details

Expected EPS
-1.094596
Actual EPS
-0.93
Surprise EPS
0.16
Surprise Percent
+15.04%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.93 per share for Q2 2026.

0 Comments

Share your thoughts